Researchers have identified six genes that predispose carriers to develop the brain tumor medulloblastoma and have used the discovery to craft genetic counseling and screening guidelines. The study appears today in the journal ...
May 9, 2018
0
26
Scientists at St. Jude Children's Research Hospital have identified a mutation that would enable the influenza virus to become resistant to a promising new class of drugs. The most advanced of these drugs are now in late ...
Apr 25, 2018
0
3
St. Jude Children's Research Hospital scientists have identified a key molecule that serves as a "security chief" to help the immune system quickly recognize and fight infections with dangerous gram-negative bacteria like ...
Mar 23, 2018
0
53
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...
Mar 16, 2018
0
171
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer peers, according to St. Jude Children's Research Hospital researchers, who hope to translate that support into better ...
Mar 8, 2018
0
50
Childhood cancer is highly curable and, through collaboration, effective treatment is possible even in a crisis, according to an analysis from St. Jude Children's Research Hospital and the Children's Cancer Center of Lebanon ...
Feb 28, 2018
0
1
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...
Jan 23, 2018
0
34
Newly identified germline variations in a key tumor suppressor gene predispose individuals to develop leukemia as children and leave them with a 1-in-4 chance of developing a second cancer later. St. Jude Children's Research ...
Jan 5, 2018
0
27
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. ...
Dec 9, 2017
0
3
St. Jude Children's Research Hospital scientists have evidence that an anti-malaria drug sensitizes a high-risk subtype of acute lymphoblastic leukemia (ALL) to treatment with a promising class of targeted drugs, raising ...
Dec 4, 2017
0
0
